TFRC and cancer: Even ex vivo lymphocytes and monocytes vary in the expression of HC-10-reactive forms when healthy controls and patients with malignancies are studied [32], with possible physiological implications, from the modulation of intracellular signals to the regulation of transferrin receptor endocytosis [27,31,33,34,35].